NCT07288034
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07288034
Title Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors City of Hope Medical Center
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
CTCA at Western Regional Medical Center Goodyear Arizona 85338 United States Details
City of Hope Corona Corona California 92882 United States Details
City of Hope Medical Center Duarte California 91010 United States Details
City of Hope Seacliff Huntington Beach California 92648 United States Details
City of Hope at Irvine Lennar Irvine California 92618 United States Details
City of Hope Antelope Valley Lancaster California 93534 United States Details
City of Hope at Long Beach Elm Long Beach California 90813 United States Details
City of Hope at Newport Beach Fashion Island Newport Beach California 92660 United States Details
City of Hope South Pasadena South Pasadena California 91030 United States Details
City of Hope South Bay Torrance California 90503 United States Details
City of Hope Upland Upland California 91786 United States Details
City of Hope Atlanta Cancer Center Newnan Georgia 30265 United States Details
City of Hope at Chicago Zion Illinois 60099 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field